- Pentagon announces tie-up with Palmer Luckey's Anduril & three other defence tech startups Times Of India —
- Anduril doubles valuation to $61B in new $5B funding round SiliconANGLE —
- Anduril raises $5B, doubles valuation to $61B Techcrunch —
- Anduril Raises $5 Billion in Funding and Is Valued at $61 Billion The New York Times —
- How SpaceX preempted a $2B fundraise with a $60B buyout offer Techcrunch —
- Pentagon reaches agreements with defense firms on containerized missiles The Hill —
- Pentagon expands missile programs with partners including Leidos, Anduril Seeking Alpha —
- Anduril Valued at $61 Billion in Round Led by Thrive, Andreessen Bloomberg —
- Microsoft looked at buying Cursor before SpaceX deal, sources say CNBC —
- Anduril CEO Weighs on $61 Billion Round Bloomberg —
- Anduril lands $5B as defense giant builds autonomous warship operation in Seattle GeekWire —
- Anduril raises $5 billion, doubling its valuation to $61 billion Quartz —
- Andreessen, Thrive Poised for Windfall From SpaceX’s Cursor Bid Bloomberg —
- Anduril doubles valuation to over $60 billion as defense tech funding boom continues CNBC —
- Exclusive: SpaceX targets in-house GPUs as it warns investors of chip supply, costs - Reuters Reuters —
- What smart people are saying about SpaceX's $60 billion deal with Cursor: 'The Hunger Games have just begun' Business Insider —
- Defence tech start-up Anduril doubles valuation to over $60bn Financial Times —
- Cursor’s 25-year-old CEO is a former Google intern who just inked a $60 billion deal with SpaceX Fortune —
- US defense firm Anduril raises $5 billion, doubling its valuation to $61 billion - Reuters Reuters —
- Meet Aman Sanger: Indian-origin co-founder of AI startup Cursor that could be acquired for $60 billion by Elon Musk’s SpaceX Times Of India —
Thrive Capital
American venture capital firm
Thrive Capital Management, LLC, commonly Thrive Capital, is an American venture capital firm based in New York City. It focuses on software and internet investments. The firm was founded by Joshua Kushner, who is also a co-founder of Oscar Health and minority owner of the Miami Heat.
Anduril valued at $61B